News

PAREXEL International is shedding up to 850 positions as part of a restructuring programme designed to ramp up productivity and efficiency. 

A £10 billion ‘megafund’ to help UK pharma firms develop new drugs will be discussed at a conference held by the mayor of London’s office today.

AbbVie has unveiled late-stage clinical trial data showing a sustained response to its all oral, interferon-free Viekirax-based hepatitis C regimen.

Basilea Pharmaceutica has launched its new broad-spectrum antibiotic Cephalosporin Zevtera across the UK for the first-line treatment of serious bacterial pneumonia, offering patients a new weapon in the fight against the infection.

Bristol-Myers Squibb is pulling the plug on its discovery research in virology as part of an R&D reshuffle plans for which first surfaced back in 2013, leading to cull of around 100 related positions.

A new YouGov poll suggests that the UK public views care for the elderly and weekend access to GPs as the top priorities for the NHS.

Roche is expanding its footprint in Africa with a new strategy designed to tap into the “growing economic might of the continent and potential to do business in”.

Organiser PharmaTimes Media is delighted to announce details of the first of the free workshops that will be running...

Join us for a glittering gala dinner at the Park Plaza Riverbank as we celebrate the achievements of sales...

The National Institute for Heath and Care Excellence is calling on employers to recognise the value of a healthy workplace, as figures show an estimated 27 million working days are lost because of work-related illness at a cost to society of some £13 billion a year.

Cost regulators for the NHS in England and Wales are asking for more information on Santen’s dry eye treatment Ikervis because the evidence provided is too uncertain.

Valeant and Progenics have filed an application in the US to market an oral form of Relistor for opioid-induced constipation in adult patients with chronic non-cancer pain.

The American Society of Clinical Oncology has designed a new conceptual framework to help doctors and patients better assess the value of new cancer treatment options based on clinical benefit, side effects, and cost.

Google has unveiled a new health-tracking wristband which it plans to position as a medical device for use by patients or clinical researchers, thus side-stepping the smartwatch-based consumer market.

The National Institute for Health and Care Excellence has updated and redesigned its guideline to help GPs better recognise the signs and symptoms of 37 different cancers, in the hope of accelerating diagnoses and saving lives.